Two-year outcomes of intravitreal brolucizumab for neovascular age-related macular degeneration: treat, extend, and stop-protocol.

Hana YoshidaSatoru InodaHidenori TakahashiRyota TakahashiYuto HashimotoHironori TakahashiHidetoshi KawashimaYasuo Yanagi

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)

UMIN Clinical Trials Registry ( http://www.umin.ac.jp/ ; R000050688 UMIN 000044374).

Keyphrases

age related macular degeneration
clinical trial
randomized controlled trial
phase ii
type diabetes
skeletal muscle
metabolic syndrome
adipose tissue
glycemic control
phase iii
optical coherence tomography
insulin resistance
double blind